PARJUPAR Study: Bromocriptine, Selegeline or Both Delay the Need of Levodopa Therapy in \"De Novo\" Parkinson\'s Disease Patients

Category Primary study
JournalPersonal communication.
Year Not known
Loading references information
This article has no abstract
Epistemonikos ID: 86c2bce1e830a5d018fd441dd31cfed52fe819a8
First added on: Sep 24, 2017